<DOC>
	<DOCNO>NCT02765347</DOCNO>
	<brief_summary>The investigator intend carry randomize , cross-over , prospective study last 48 week youth T1DM follow center . The purpose observe effect metformin glycemic control insulin sensitivity adolescent T1DM base insulin therapy use 72h CGMS hyperinsulinemic euglycemic clamp .</brief_summary>
	<brief_title>The Effects Metformin Glycemic Control Insulin Sensitivity Adolescents With T1DM</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Insulin Resistance</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 1</mesh_term>
	<mesh_term>Insulin , Globin Zinc</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<mesh_term>Metformin</mesh_term>
	<criteria>1 . Type 1 diabetes mellitus ; 2 . Age≥12 yr ; 3 . Tanner sexual maturation rating 25 ; 4 . HbA1c level : 7.5 % 10 % ; 5 . MDI CSII ≥6 month ; 6 . Insulin dose ≥ 0.8U/kg enrollment，and dosage stable least ＞1 month（dosage change &lt; 10 % ） . 1 . Serious acute chronic complication associate diabetes ; 2 . Repeated serious hypoglycemia episode repeatedly ; 3 . Hepatic function damage ( ALT≥2.5 time high upper limit normal accepted range ) ; 4 . Moderate advance renal impairment ( calculate accord MDRD equation : eGFR &lt; 60ml/min/1.73m2 ) ; 5 . Clinically significant heart attack : myocardial infarction , arrhythmia，IIIII°AVB，unstable angina，decompensated HF（NYHA III~IV ; 6 . Female patient sex life willing use contraceptive method ; 7 . Pregnancy .</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2016</verification_date>
</DOC>